We also found that high TMEM52B expression in lung and breast cancer patients was significantly correlated with increased overall survival and relapse-free survival, respectively, when survival within previously published data sets was analyzed using the KM-plotter. The gene discussed is TMEM52B; the disease is breast carcinoma.